- /
- Supported exchanges
- / US
- / TXG.NASDAQ
10X Genomics Inc (TXG NASDAQ) stock market data APIs
10X Genomics Inc Financial Data Overview
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with 10X Genomics Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get 10X Genomics Inc data using free add-ons & libraries
Get 10X Genomics Inc Fundamental Data
10X Genomics Inc Fundamental data includes:
- Net Revenue: 642 M
- EBITDA: -97 499 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-28
- EPS/Forecast: -0.07
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
10X Genomics Inc News
New
This TSX transportation stock is up 17% this week and analysts see more upside potential
Shares of heavy duty bus maker NFI Group Inc. rebounded this week on the S&P/TSX composite index. (Credit: Handout) Desjardins’s 2026 top picks, food inflation winners and more stories from The Wee...
Tempus AI Turns Non-GAAP Profit on Surging Genomics and Data
Tempus AI TEM reported non-GAAP profit in the third quarter of 2025 as genomics testing and data services gained momentum. The stock carries a Zacks Rank #3 (Hold) with a VGM Score of D. It is weak on...
Tempus AI Revenue Jumps 85% as Pricing Catalysts Line Up
Tempus AI TEM posted another breakout quarter as diagnostics volumes and pricing improved while data partnerships extended visibility. Execution on mix, reimbursement and bookings sets a clearer path ...
Tempus AI Near $75 Target? Valuation, Upside and Risks
Tempus AI TEM has rallied hard in 2025 and now trades close to its 6–12 month target. Progress from regulators and steady execution will be key. The trend is strong, but slow booking-to-revenue con...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.